A prospective, randomized, multi-center double-blind study of early corticosteroid cessation vs. long term corticosteroid therapy with Prograf [tacrolimus] and CellCept [mycophenolate mofetil] in primary renal transplant patients

Trial Profile

A prospective, randomized, multi-center double-blind study of early corticosteroid cessation vs. long term corticosteroid therapy with Prograf [tacrolimus] and CellCept [mycophenolate mofetil] in primary renal transplant patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 12 Nov 2012

At a glance

  • Drugs Methylprednisolone; Mycophenolate mofetil; Prednisone; Tacrolimus
  • Indications Renal transplant rejection
  • Focus Pharmacokinetics; Therapeutic Use
  • Sponsors Astellas Pharma
  • Most Recent Events

    • 16 Apr 2008 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top